Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Inventory (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Change in Inventory for 15 consecutive years, with -$900000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 169.23% to -$900000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.2 million, a 48.39% decrease, with the full-year FY2025 number at $3.2 million, down 48.39% from a year prior.
  • Change in Inventory was -$900000.0 for Q4 2025 at Myriad Genetics, down from $2.9 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $4.3 million in Q3 2022 to a low of -$3.2 million in Q4 2021.
  • A 5-year average of $657894.7 and a median of $800000.0 in 2021 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: tumbled 192.31% in 2021, then skyrocketed 750.0% in 2023.
  • Myriad Genetics' Change in Inventory stood at -$3.2 million in 2021, then skyrocketed by 53.12% to -$1.5 million in 2022, then plummeted by 113.33% to -$3.2 million in 2023, then skyrocketed by 140.62% to $1.3 million in 2024, then tumbled by 169.23% to -$900000.0 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Change in Inventory are -$900000.0 (Q4 2025), $2.9 million (Q3 2025), and $300000.0 (Q2 2025).